A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice
Molecular Therapy: Methods & Clinical Development, 32(2), 101269
Marine Biodiscovery
Marine scientist and biochemist interested in bioprospecting in the deep sea and extreme marine habitats. Joining University of Florida’s Whitney Laboratory for Marine Bioscience in August 2026 to investigate biomineralization and help develop the sea anemone Nematostella vectensis as a platform for protein expression. More about my incoming work →
Molecular Therapy: Methods & Clinical Development, 32(2), 101269
This study evaluated a blood-brain barrier-penetrant gene therapy for symptomatic mucolipidosis IV in mice. I contributed in vivo retinal imaging, retinal-layer segmentation, and quantitative thickness analysis.
If we crossed paths at ASP 2026, or you work in natural products and biodiscovery, I would be glad to connect.